MedMen Enterprises Inc

MedMen Enterprises — Merger or Acquisition (August 2021)

13 slides from MedMen Enterprises's merger presentation, Aug 20, 2021

  1. Slide 1: MedMen and Tilray

    sé MedMen « 4) TILRAY AUGUST 17, 2021

  2. Slide 2: MedMen Disclaimer

    2021© MEDMEN - TILRAY MEDMEN DISCLAIMER IMPORTANT: YOU MUST READ THE FOLLOWING BEFORE CONTINUING The information contained in this presentation has been prepared by MedMen Enterprises Inc. (“MedMen” or “the Company”) and c ont ains information pertaining to the business, operations, assets and prosp

  3. Slide 3: Tilray Forward-Looking Statements

    2021© MEDMEN - TILRAY TILRAY FORWARD - LOOKING STATEMENTS 3 Cautionary Statement Concerning Tilray Forward - Looking Statements Certain statements contained in this presentation constitute "forward - looking statements" within the meaning of federal securities laws, including the Private Securities

  4. Slide 4: Table of Contents

    2021© MEDMEN - TILRAY Table of Contents 4 I Transaction Overview 5 II The Future of the U.S. Cannabis Market 7 III MedMen : Leading U.S. Retail Cannabis Brand 8 IV Tilray: Potential Accelerated Path into the U.S. Cannabis Market 11

  5. Slide 5: Transaction Overview

    2021© MEDMEN - TILRAY Transaction Overview 5 Strategic transaction enables MedMen, a premier U.S. cannabis retailer, to reshape its balance sheet and accelerate its growth trajectory, and provides Tilray, the leading global cannabis consumer packaged goods company, with a potential accelerated path

  6. Slide 6: Powerful Strategic Benefits for MedMen and Tilray

    2021© MEDMEN - TILRAY Powerful Strategic Benefits for MedMen and Tilray 6 • Favorable amendment and extension of notes that were otherwise scheduled to be maturing in the near - term shifts focus to prioritizing new market opportunities and improving existing operations over near - term balance shee

  7. Slide 7: U.S. Cannabis Market – State of Play and Anticipated Timeline

    2021© MEDMEN - TILRAY U.S. Cannabis Market – State of Play and Anticipated Timeline Largest Cannabis Market in the World - 8x the size of the Canadian market $80B US MARKET 1 Favorable trends towards legalization at the Federal level • Sen. Schumer’s Cannabis Administration & Opportunity Act latest

  8. Slide 8: MedMen has Executed on its Turnaround Plan

    2021© MEDMEN - TILRAY $26.8 $9.2 Q2 FY20 Q3 FY20 Q4 FY20 Q1 FY21 Q2 FY21 MedMen has Executed on its Turnaround Plan Under new leadership since 2020, MedMen has executed on a robust turnaround plan designed to right - size the business, improve its liquidity position, and provide a strong foundation

  9. Slide 9: MedMen has a Nationally Recognized Brand and Loyal Customer Base

    2021© MEDMEN - TILRAY MedMen has a Nationally Recognized Brand and Loyal Customer Base 9 • Accomplished Brand Builders : MedMen’s roots are in marketing, branding and creative design – the Company pioneered large - scale advertising to help de - stigmatize cannabis in the U.S. • Best - in - Class Le

  10. Slide 10: MedMen has an Expansive, Strategic License Footprint

    2021© MEDMEN - TILRAY MedMen has an Expansive, Strategic License Footprint 10 IL : Leading Midwest Cannabis Market with ~$1B in legal sales 4 ; MedMen has a growing position MA : MedMen poised to open two of the most well - located dispensaries in a limited - license market Source: Company managemen

  11. Slide 11: Tilray: Upon Legalization, Potential to Develop U.S. Leadership Position

    2021© MEDMEN - TILRAY Tilray : Upon Legalization, Potential to Develop U.S. Leadership Position 11 • MedMen arguably has the best - known and internationally - recognized retail and consumer cannabis brand • Strong roots in marketing, branding and creative design has generated strong brand loyalty a

  12. Slide 12: TILRAY Berrin Noorata - Media 519.551.6081 news@Tilray.com Raphael Gross at ICR - IR 203.682.8253

    TILRAY Berrin Noorata - Media 519.551.6081 news@Tilray.com Raphael Gross at ICR - IR 203.682.8253 raphael.gross@icrinc.com MEDMEN Lisa Weser at Trailblaze - Media MedMen@Trailblaze.co Morry Brown - IR investors@MedMen.com &

  13. Slide 13: Appendix: Non-GAAP Reconciliation

    2021© MEDMEN - TILRAY Appendix: Non - GAAP Reconciliation 13

MedMen Enterprises — Merger or Acquisition (August 2021) on 6ix